Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
By Patrick Wingrove (Reuters) -Novavax (NVAX) cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ...
Read moreDetailsTag: annual revenue
- Trending
- Comments
- Latest
